Simplifying Global Compliance
The QMN Weekly Bulletin
AstraZeneca Acquires Chinese Generic Firm, Fires 1100 Employees
Dec. 9, 2011
AstraZeneca is all set to increase its footprint in China as the company took one more step in that direction recently by the acquisition of a Chinese generic injectable antibiotics manufacturer.
Beacon Equity Research
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing